Future mechanistic and translational work should determine whether persistent PRKAG2 stabilization represents a biomarker of adaptive neural metabolism or a viable target for interventions aimed at preventing diabetes-related neurodegeneration. Here, PRKAG2 is linked to diabetes mellitus.